SRP4121
IGF-I from rat
recombinant, expressed in E. coli, ≥95% (SDS-PAGE), ≥95% (HPLC)
Manufacturer: Sigma Aldrich
Synonym(S): IGF-I, IGF1, IGFIA, Somatomedin C
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 20 μG | SRP4121-20-μG | In Stock | ₹ 34,943.10 |
SRP4121 - 20 μG
In Stock
Quantity
1
Base Price: ₹ 34,943.10
GST (18%): ₹ 6,289.758
Total Price: ₹ 41,232.858
biological source
rat
recombinant
expressed in E. coli
Assay
≥95% (HPLC)≥95% (SDS-PAGE)
form
lyophilized
mol wt
~7.69 kDa
packaging
pkg of 20 μg
storage condition
avoid repeated freeze/thaw cycles
impurities
endotoxin, tested
NCBI accession no.
P08025
UniProt accession no.
P08025
Description
- General description: IGF-I (insulin-like growth factor-I) is a member of a family of polypeptide growth factors. Rat IGF-I is a 7.69kDa protein containing 70 amino acid residues.
- Application: IGF-I (Insulin-like Growth Factor-I) from rat has been used to study the the effect of IGF-I, IL-27 (interleukin-27) and IL-35 on the blood flow in the inflamed joints of rats.[2]
- Biochem/physiol Actions: IGF-I (Insulin-like growth factor-I) is a polypeptide growth factor that stimulates the proliferation of a wide range of cell types including muscle, bone and cartilage tissue. It mainly mediates growth and development. IGF-I is required for fetal growth and development.[4] It is also involved in the growth and repair of heart tissues.[5] IGF-I has been linked to neuroplasticity and hippocampal neurogenesis.[6] It is important in the recovery from ischaemic injury.[7]
- Physical form: Lyophilized without additives.
- Reconstitution: Centrifuge the vial prior to opening. Avoid freeze-thaw cycles.
SAFETY INFORMATION
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Compare Similar Items
Show Difference
biological source: rat
recombinant: expressed in E. coli
Assay: ≥95% (HPLC)≥95% (SDS-PAGE)
form: lyophilized
mol wt: ~7.69 kDa
packaging: pkg of 20 μg
storage condition: avoid repeated freeze/thaw cycles
impurities: endotoxin, tested
NCBI accession no.: P08025
UniProt accession no.: P08025
biological source:
rat
recombinant:
expressed in E. coli
Assay:
≥95% (HPLC)≥95% (SDS-PAGE)
form:
lyophilized
mol wt:
~7.69 kDa
packaging:
pkg of 20 μg
storage condition:
avoid repeated freeze/thaw cycles
impurities:
endotoxin, tested
NCBI accession no.:
P08025
UniProt accession no.:
P08025
biological source: human
recombinant: expressed in E. coli
Assay: ≥98% (HPLC)≥98% (SDS-PAGE)
form: lyophilized
mol wt: ~15.0 kDa
packaging: pkg of 10 μg
storage condition: __
impurities: endotoxin, tested
NCBI accession no.: P08700
UniProt accession no.: __
biological source:
human
recombinant:
expressed in E. coli
Assay:
≥98% (HPLC)≥98% (SDS-PAGE)
form:
lyophilized
mol wt:
~15.0 kDa
packaging:
pkg of 10 μg
storage condition:
__
impurities:
endotoxin, tested
NCBI accession no.:
P08700
UniProt accession no.:
__
biological source: mouse
recombinant: expressed in E. coli
Assay: ≥98% (HPLC)≥98% (SDS-PAGE)
form: lyophilized
mol wt: ~15.1 kDa
packaging: pkg of 10 μg
storage condition: __
impurities: endotoxin, tested
NCBI accession no.: P01586
UniProt accession no.: __
biological source:
mouse
recombinant:
expressed in E. coli
Assay:
≥98% (HPLC)≥98% (SDS-PAGE)
form:
lyophilized
mol wt:
~15.1 kDa
packaging:
pkg of 10 μg
storage condition:
__
impurities:
endotoxin, tested
NCBI accession no.:
P01586
UniProt accession no.:
__
biological source: human
recombinant: expressed in E. coli
Assay: ≥98% (HPLC)≥98% (SDS-PAGE)
form: lyophilized
mol wt: ~15.0 kDa
packaging: pkg of 10 μg
storage condition: __
impurities: endotoxin, tested
NCBI accession no.: P05112
UniProt accession no.: __
biological source:
human
recombinant:
expressed in E. coli
Assay:
≥98% (HPLC)≥98% (SDS-PAGE)
form:
lyophilized
mol wt:
~15.0 kDa
packaging:
pkg of 10 μg
storage condition:
__
impurities:
endotoxin, tested
NCBI accession no.:
P05112
UniProt accession no.:
__